Pages that link to "Q34496831"

The following pages link to Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis (Q34496831):

Displaying 41 items.

• Evolving landscape in the management of transthyretin amyloidosis (Q28086773) (← links)
• Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity (Q28551199) (← links)
• Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. (Q33978484) (← links)
• The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry (Q34073701) (← links)
• Guideline of transthyretin-related hereditary amyloidosis for clinicians. (Q34328734) (← links)
• FAP neuropathy and emerging treatments (Q34401190) (← links)
• Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy (Q34422510) (← links)
• Binding site asymmetry in human transthyretin: insights from a joint neutron and X-ray crystallographic analysis using perdeuterated protein (Q34473216) (← links)
• Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission (Q34549794) (← links)
• Recent advances in transthyretin amyloidosis therapy (Q34664696) (← links)
• Clinical and laboratory characteristics of patients having amyloidogenic transthyretin deposition in osteoarthritic knee joints (Q35081979) (← links)
• Experimentally Derived Structural Constraints for Amyloid Fibrils of Wild-Type Transthyretin (Q35556296) (← links)
• Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition (Q35850786) (← links)
• Updates in cardiac amyloidosis: a review. (Q36366356) (← links)
• Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry (Q36517698) (← links)
• Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy (Q36559736) (← links)
• (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis (Q36740688) (← links)
• Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity (Q37141705) (← links)
• An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Seri (Q37681076) (← links)
• The amyloid state of proteins in human diseases (Q37994283) (← links)
• The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption (Q38367420) (← links)
• Advances in proteomic study of cardiac amyloidosis: progress and potential. (Q38809423) (← links)
• One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition (Q39091511) (← links)
• Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. (Q43984985) (← links)
• Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy (Q44058505) (← links)
• Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. (Q44155172) (← links)
• Systemic AA amyloidosis in the red fox (Vulpes vulpes). (Q46323685) (← links)
• Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis (Q47361404) (← links)
• Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis (Q47404960) (← links)
• Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. (Q47561760) (← links)
• CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects. (Q47924309) (← links)
• Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients (Q57259391) (← links)
• The challenging histological diagnosis of transthyretin (ATTR) amyloidosis (Q58125001) (← links)
• Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis (Q58157807) (← links)
• Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid (Q58248637) (← links)
• Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening (Q60302270) (← links)
• Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families (Q64097528) (← links)
• Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis (Q85252139) (← links)
• Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition (Q89321655) (← links)
• Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis (Q91062542) (← links)
• New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience (Q92489456) (← links)